Dr. Thomas Ulas
Life & Medical Sciences Institute (LIMES)
t.ulas@uni-bonn.de View member: Dr. Thomas Ulas
The Journal of allergy and clinical immunology
BACKGROUND: Scavenger receptor CD163 is exclusively expressed on monocytes/macrophages and is widely used as a marker for alternatively activated macrophages. However, the role of CD163 is not yet clear.
OBJECTIVES: We sought to examine the function of CD163 in steady-state as well as in sterile and infectious inflammation.
METHODS: Expression of CD163 was analyzed under normal and inflammatory conditions in mice. Functional relevance of CD163 was investigated in models of inflammation in wild-type and CD163 mice.
RESULTS: We describe a subpopulation of bone marrow-resident macrophages (BMRMs) characterized by a high expression of CD163 and functionally distinct from classical bone marrow-derived macrophages. Development of CD163 BMRMs is strictly dependent on IFN regulatory factor-8. CD163 BMRMs show a specific transcriptome and cytokine secretion pattern demonstrating a specific immunomodulatory profile of these cells. Accordingly, CD163 mice show a stronger inflammation in allergic contact dermatitis, indicating a regulatory role of CD163. However, CD163 mice are highly susceptible to S aureus infections, demonstrating the relevance of CD163 for antimicrobial defense as well.
CONCLUSIONS: Our data indicate that anti-inflammatory and immunosuppressive mechanisms are not necessarily associated with a decreased antimicrobial activity. In contrast, our data define a novel macrophage population that controls overwhelming inflammation on one hand but is also necessary for an effective control of infections on the other hand.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
PMID: 32199911
Life & Medical Sciences Institute (LIMES)
t.ulas@uni-bonn.de View member: Dr. Thomas UlasLife & Medical Sciences Institute (LIMES)
j.schultze@uni-bonn.de View member: Prof. Dr. med. Joachim L. Schultze